Literature DB >> 1536799

The neurologic aspects of transcobalamin II deficiency.

C A Hall1.   

Abstract

Thirty-four symptomatic cases of inherited transcobalamin II (TCII) deficiency were analysed in order to determine the frequency and nature of neurologic manifestations. In no instance was there definite evidence of a neurologic disorder at the time of presentation as a young infant. One child of 2 1/2 years transiently lost deep tendon reflexes at a time of suboptimal treatment. A syndrome of mental retardation and other neurologic manifestations was observed in three cases, all with the following in common: (1) an extended duration of illness of 2-17 years; (2) inadequate or not treatment with Cbl; (3) treatment with folic of folinic acid. TCII deficiency rarely if ever presents with neurologic manifestations. However, neurologic disorders can be produced subsequently by improper treatment.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1536799     DOI: 10.1111/j.1365-2141.1992.tb06410.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  8 in total

1.  Should transcobalamin deficiency be treated aggressively?

Authors:  Manuel Schiff; Hélène Ogier de Baulny; Ghislaine Bard; Vincent Barlogis; Christian Hamel; Stuart J Moat; Sylvie Odent; Graham Shortland; Guy Touati; Stéphane Giraudier
Journal:  J Inherit Metab Dis       Date:  2010-03-30       Impact factor: 4.982

2.  Hereditary transcobalamin II deficiency: a 22 year follow up.

Authors:  P K Thomas; A V Hoffbrand
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-02       Impact factor: 10.154

3.  Transcobalamin II deficiency with methylmalonic aciduria in three sisters.

Authors:  H Bibi; Z Gelman-Kohan; E R Baumgartner; D S Rosenblatt
Journal:  J Inherit Metab Dis       Date:  1999-10       Impact factor: 4.982

4.  Multifocal anaplastic astrocytoma in a patient with hereditary colorectal cancer, transcobalamin II deficiency, agenesis of the corpus callosum, mental retardation, and inherited PMS2 mutation.

Authors:  Sridharan Gururangan; Wendy Frankel; Russell Broaddus; Mark Clendenning; Leigha Senter; Marie McDonald; James Eastwood; David Reardon; James Vredenburgh; Jennifer Quinn; Henry S Friedman
Journal:  Neuro Oncol       Date:  2007-11-09       Impact factor: 12.300

5.  Transcobalamin (TC) deficiency--potential cause of bone marrow failure in childhood.

Authors:  C Prasad; D S Rosenblatt; K Corley; A E L Cairney; C A Rupar
Journal:  J Inherit Metab Dis       Date:  2008-10-29       Impact factor: 4.982

6.  Update on transcobalamin deficiency: clinical presentation, treatment and outcome.

Authors:  Y J Trakadis; A Alfares; O A Bodamer; M Buyukavci; J Christodoulou; P Connor; E Glamuzina; F Gonzalez-Fernandez; H Bibi; B Echenne; I Manoli; J Mitchell; M Nordwall; C Prasad; F Scaglia; M Schiff; B Schrewe; G Touati; M C Tchan; B Varet; C P Venditti; D Zafeiriou; C A Rupar; D S Rosenblatt; D Watkins; N Braverman
Journal:  J Inherit Metab Dis       Date:  2013-12-05       Impact factor: 4.982

7.  A novel TCN2 mutation with unusual clinical manifestations of hemolytic crisis and unexplained metabolic acidosis: expanding the genotype and phenotype of transcobalamin II deficiency.

Authors:  Pongpak Pongphitcha; Nongnuch Sirachainan; Arthaporn Khongkraparn; Thipwimol Tim-Aroon; Duantida Songdej; Duangrurdee Wattanasirichaigoon
Journal:  BMC Pediatr       Date:  2022-04-29       Impact factor: 2.567

8.  Transcobalamin II Deficiency in Four Cases with Novel Mutations.

Authors:  Şule Ünal; Tony Rupar; Sevgi Yetgin; Neşe Yaralı; Ali Dursun; Türkiz Gürsel; Mualla Çetin
Journal:  Turk J Haematol       Date:  2015-04-27       Impact factor: 1.831

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.